OAM
RLAY icon

OP Asset Management’s Relay Therapeutics RLAY Stock Holding History

OP Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,217
Closed -$291K – 821
2026
Q1 		$291K Buy
+29,217
New +$261K ﹤0.01% 710
2025
Q3 		– Sell
-70,542
Closed -$244K – 851
2025
Q2 		$244K Buy
+70,542
New +$210K ﹤0.01% 724

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

OP Asset Management's RLAY Position: Q2 2026 in Review

OP Asset Management sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 29,217 shares — an estimated $291K sold.

OP Asset Management first reported a position in RLAY in Q2 2025 and held it in 2 quarters. The position peaked at $291K in Q1 2026. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • OP Asset Management reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 29,217 Relay Therapeutics shares in Q2 2026, an estimated $291K.
  • OP Asset Management first reported a position in Relay Therapeutics in Q2 2025 and held it in 2 quarters.
  • OP Asset Management's Relay Therapeutics position peaked at $291K in Q1 2026.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.